Sun Pharmaceutical Industries, India's largest pharma company, announced the closure of its merger with Ranbaxy Laboratories. This makes them world's fifth largest maker of generic drugs.
FDA Issues Recall of 200 Vials of Sun Pharma's Chemo Drug
The US Food and Drug Administration has announced that it has recalled around 200 vials of a chemotherapy drug.
The US Food and Drug Administration has announced that it has recalled around 200 vials of a chemotherapy drug.
The Punjab and Haryana High Court approved the merger earlier this month, while the US Federal Trade Commission (FTC) had approved the merger in January 2015. On March 23, the Competition Commission of India (CCI) had approved the Sun Pharmaceutical and Ranbaxy sale of seven brands to Emcure Pharma to comply with the conditional nod for their merger.
Source-Medindia
Sun Pharma Issues Recall for Two Drugs in US Market
Trouble deepened for Sun Pharmaceuticals after it was forced to recall over 4 lakh bottles of anti-depressant and anti-allergy drugs.
Trouble deepened for Sun Pharmaceuticals after it was forced to recall over 4 lakh bottles of anti-depressant and anti-allergy drugs.
Sun Pharma�s ANDA for Azelastine Nasal Spray Gets FDA Nod
un Pharmaceuticals has revealed that its abbreviated new drug application for Azelastine HCL nasal spray has been approved by the US FDA.
un Pharmaceuticals has revealed that its abbreviated new drug application for Azelastine HCL nasal spray has been approved by the US FDA.
Ranbaxy Gets the Nod to Commence Distribution of Its Anti-malarial Drug in 7 African Countries
The Indian multinational pharmaceutical company, Ranbaxy Laboratories has received regulatory nod to launch its indigenously developed anti-malarial drug, Synriam, in seven African countries.
The Indian multinational pharmaceutical company, Ranbaxy Laboratories has received regulatory nod to launch its indigenously developed anti-malarial drug, Synriam, in seven African countries.
